Plus   Neg

TUI Signs Sale And Leaseback Deal With BOC Aviation For 5 New Boeing 737 MAX-8 For $226 Mln

Tour operator TUI AG (TUIFF.PK) Monday confirmed the signing of a sale and leaseback or SLB agreement with BOC Aviation Ltd for five new Boeing 737 MAX-8 aircraft for the aggregate sum of $226 million or around 193 million euros.

The first aircraft is expected for delivery in the first quarter of fiscal 2021, while the remaining four aircraft are expected to be delivered ahead of the Summer 2021 season.

TUI noted that SLB agreement with BOC Aviation, in line with its asset-right strategy, will finance five new Boeing 737 MAX-8 aircraft as part of its planned re-fleeting programme.

The company expects the lease agreement with BOC Aviation would create a total lifetime lease obligation of around 223 million euros to commence by the end of fiscal 2021.

The company expects further SLB financing on its future deliveries beyond fiscal 2021, in line with its newly agreed deferred re-fleeting programme with Boeing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT